Projects per year
Fingerprint
Dive into the research topics where Martin Pecherstorfer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Red flags
Pecherstorfer, M., Wieser, M., Rausch, F. G. & Partner, P.
Gesellschaft für Forschungsförderung NÖ
20.01.22 → 19.01.25
Project: Funded Research
-
APOG: ACCESS POINT Oncology
Podar, K., Stoiber-Sakaguchi, D., Pecherstorfer, M., Georg, P., Kieseberg, P. & Fossati, P.
01.01.20 → 31.12.24
Project: Funded Research
-
Tumor Cachexia
Pecherstorfer, M., Zwickl, H., Eger, A., Gerner, C., Köfeler, H., König, F. & Ludvik, B.
Gesellschaft für Forschungsförderung NÖ
01.02.16 → 31.07.20
Project: Funded Research
Research output
-
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study
Wirth, S. R. M., Podar, K., Pecherstorfer, M., Wohlfarth, P., Jaeger, U. & Singer, J., 14 Jan 2023, In: Cancers. 15, 2, p. 524 524.Research output: Journal article (peer-reviewed) › Journal article
Open Access1 Citation (Scopus) -
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300Research output: Journal article (peer-reviewed) › Conference contribution to journal
Open Access -
Evaluation of diagnostic and treatment approaches to acute dyspnea in a palliative care setting among medical doctors with different educational levels
Hackner, K., Heim, M., Masel, E. K., Riedl, G., Weber, M., Strieder, M., Danninger, S., Pecherstorfer, M. & Kreye, G., Jul 2022, In: Supportive Care in Cancer. 30, 7, p. 5759-5768 10 p.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, In: Expert Opinion on Pharmacotherapy. 23, 12, p. 1425-1444 20 p.Research output: Journal article (peer-reviewed) › Review article
1 Citation (Scopus) -
Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy – Update: OeGHO Frühjahrstagung, 8.-10.4.2021, Online
Lind, J., Czernilofsky, F., Vallet, S., Fan, F., Bakiri, L., Wagner, E. F., Sattler, M., Pecherstorfer, M. & Podar, K., 2021, In: Memo - Magazine of European Medical Oncology. 14, Suppl. 2, p. 23-41 19 p.Research output: Journal article (peer-reviewed) › Conference contribution to journal
Open Access